Skip to content

MedGD

Active
Private limited companyfounded 20241 yr activeRue des Jardins,Jemelle 37, 5580 Rochefort, BelgiumKBO/BCE: BE 1017.589.089
Summary

The computed 12-month bankruptcy probability of MedGD is 1.6% (moderate). The 2025 annual accounts show equity of €147,715 and a net result of €142,715. The company has been active since 2024 and the Belgian State Gazette contains no insolvency or warning signals.

Checked score

Score 2025
Axes
Profitability100
Solvency100
Growth-
Track record67
Bankruptcy probability, 12 months
1.6% Moderate
0%0.5%1.5%4%10%≥ 25%
Credit up to €11,000 at 30 days only on tighter terms
Liquidity ample (current ratio 6.43; short-term debt: 13.8% and cash: 17.4% of total assets), and 13.8% of the assets are financed with debt.
Credit check for your own amount and term

Open the credit simulator : see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · No NACE activity registered
No NACE activity is registered in the KBO, which is more common among companies that later fail.
KBO · activities
raises risk · Young company
A young company has little track record yet and statistically fails more often than an established one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 1 year 0 10 y
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
86.2%
Return on assets
83.3%
Age of the figures
9 mo
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 07-08-2026, 7 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 1 filing
Deviation from the deadline
2025
7 d late
← before the deadline after the deadline →
Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

On 18 December 2024, MedGD was incorporated as a Private limited company.1 The company has filed annual accounts once, for fiscal year 2025.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2025

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, micro schema

Equity
€147,715
Total assets
€171,317
Net result
€142,715
Working capital
€128,121

Turnover and EBIT margin not published: the micro schema does not require them.

Balance-sheet composition
Assets €171,317
Fixed assets €19,594
Current assets €151,723
Equity and liabilities €171,317
Equity €147,715
Debt €23,601
Debt finances 13.8% of the balance-sheet total.
Key figures and ratios
2025 value
EBITDA
€192,859
Cash flow
€148,831
Current ratio
6.43
Debt to equity
0.16
ROE
96.6%
ROA
83.3%
Interest coverage
341.71
Debt ≤ 1 year
€23,601
Income taxes
€43,463
Staff costs
€269
Annual accounts
Filed annual accounts As filed with the NBB · 2025 · 31 lines
Balance sheet Code2025
Assets
Total assets20/58€171,317
Fixed assets21/28€19,594
Tangible fixed assets22/27€19,594
Furniture and vehicles24€19,594
Current assets29/58€151,723
Current investments50/53€120,000
Cash at bank and in hand54/58€29,893
Deferred charges and accrued income490/1€1,830
Equity and liabilities
Total equity and liabilities10/49€171,317
Equity10/15€147,715
Contributions10/11€5,000
Profit (loss) carried forward14€142,715
Amounts payable17/49€23,601
Amounts payable within one year42/48€23,601
Trade debts44€17,438
Suppliers440/4€17,438
Taxes, remuneration and social security45€6,163
Taxes450/3€163
Remuneration and social security454/9€6,000
Income statement Code2025
Remuneration, social security and pensions62€269
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€6,116
Other operating charges640/8€239
Gross operating margin9900€193,366
Operating profit (loss)9901€186,743
Financial charges65/66B€564
Recurring financial charges65€564
Profit (loss) for the period before taxes9903€186,179
Income taxes67/77€43,463
Profit (loss) for the period9904€142,715
Profit (loss) for the period to be appropriated9905€142,715
Appropriation of the result
Profit (loss) to be appropriated9906€142,715

The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line2025
Remuneration, social security and pensions62€269
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€6,116
Other operating charges640/8€239
Gross operating margin9900€193,366
Operating profit (loss)9901€186,743
Financial charges65/66B€564
Recurring financial charges65€564
Profit (loss) for the period before taxes9903€186,179
Income taxes67/77€43,463
Profit (loss) for the period9904€142,715
Profit (loss) for the period to be appropriated9905€142,715
Line2025
Assets
Total assets20/58€171,317
Fixed assets21/28€19,594
Tangible fixed assets22/27€19,594
Furniture and vehicles24€19,594
Current assets29/58€151,723
Current investments50/53€120,000
Cash at bank and in hand54/58€29,893
Deferred charges and accrued income490/1€1,830
Equity and liabilities
Total equity and liabilities10/49€171,317
Equity10/15€147,715
Contributions10/11€5,000
Profit (loss) carried forward14€142,715
Amounts payable17/49€23,601
Amounts payable within one year42/48€23,601
Trade debts44€17,438
Suppliers440/4€17,438
Taxes, remuneration and social security45€6,163
Taxes450/3€163
Remuneration and social security454/9€6,000
Line2025
Profit (loss) for the period9904€142,715
+ Depreciation and write-downs630€6,116
Operating cash flow (approximation)€148,831

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

2026
07-08
NBB filing Annual accounts filed
fiscal year 2025 · micro schema · 7 days late
NBB filing

Directors · office · real estate

Directors
We have established no sitting directors for this company. We derive directors from published Gazette acts; while there are none, or none read, nothing appears here. That does not mean the company has none: the CBE keeps its own list of function holders, which we do not read.
Location & real-estate footprint
Registered office, Rochefort · 1 establishment unit since 2024
seat establishment approximate The establishment unit on the map
Ground area
800 m²
Parcel 91075A0535/00V002, Wallonia. Linked by address, not a title deed.
1 establishment unit
MedGD
Rue des Jardins,Jemelle 37, 5580 RochefortGeneral medical practice
since 20242.367.506.912
1 parcel
Wallonia 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
91075A0535/00V002 Wallonia 800 m² - -
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Identification & contact

Identification
Legal formPrivate limited company
Founded18-12-2024
Fiscal year end31-12
Contact
E-mail docteur.dufoing@gmail.com
Phone +3284480114

Scores and ratios are computed by Checked and are not a credit decision.